CTMX - CytomX Therapeutics Stock Trading
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated antibody therapeutics based on its Probody ®...
-
Image source: The Motley Fool. CytomX Therapeutics, Inc. (NASDAQ: CTMX) Q4 2020 Earnings Call Feb 24, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: CytomX Therapeutics, Inc. (CTMX) Q4 2020 Earnings Call Transcript...
-
-Broad advancement of clinical pipeline- -Three-arm Phase 2 study of praluzatamab ravtansine (CX-2009) launched in breast cancer- -Enrollment continues in Phase 2 expansion study of CX-2029 in four cancer types, in partnership with AbbVie- -Bristol Myers Squibb e...